Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$5.69 – $9.22
17% from low
Exchange
OTC Link
ADRC
Borrow rate
15.82%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $642.83B | $695.62B | $645.94B | $756.23B | $744.40B | $741.75B | $789.40B | $875.15B |
| Cost of revenue | $184.49B | $175.69B | $161.31B | $174.83B | $177.84B | $155.33B | $168.81B | $202.76B |
| Gross profit | $458.34B | $519.93B | $484.63B | $581.39B | $566.57B | $586.42B | $620.59B | $672.40B |
| Gross margin | 71.3% | 74.7% | 75.0% | 76.9% | 76.1% | 79.1% | 78.6% | 76.8% |
| R&D | $144.84B | $140.12B | $150.30B | $171.74B | $173.00B | $169.02B | $171.63B | $168.23B |
| Operating income | $86.15B | $125.50B | $53.22B | $53.75B | $40.04B | $53.41B | $54.38B | $42.63B |
| EBITDA | $117.75B | $162.94B | $89.52B | $94.55B | $87.26B | $103.11B | $104.49B | $95.31B |
| Net income | $63.39B | $121.77B | $41.94B | $47.95B | $55.43B | $42.41B | $46.43B | $40.88B |
| Net margin | 9.9% | 17.5% | 6.5% | 6.3% | 7.4% | 5.7% | 5.9% | 4.7% |
| EPS (diluted) | 55.26 | 106.20 | 36.73 | 41.81 | 48.33 | 36.97 | 40.94 | 36.75 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $865.7B | $39.14 | $37.16–$41.34 | 1 |
| 2028 | $153.18T | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
EISAI CO LTD U/ADR
No one on the platform currently holds ESAIY.
No tracked institution reports a position in ESAIY as of their last filing.
No one on the platform has traded ESAIY yet.
| $7.6B |
| — |
| NOBDFNorth Bud Farms Inc. | $0.00 | +0.00% | $634 | — |
| SFOSFShanghai Fosun Pharmaceutical (Group) Co., Ltd. | $2.02 | +0.00% | $5.3B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.2× earnings vs its 0.2× historical median P/E.
Fair value ≈ $9.89 · price $6.30 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.